Gwenael Jan

Title: Gwenael Jan: Innovator in Immunomodulatory Research

Introduction

Gwenael Jan is a notable inventor based in Rennes, France. He has made significant contributions to the field of immunomodulatory research, particularly through his innovative patents. With a total of 2 patents, Jan's work focuses on the treatment and prevention of inflammatory diseases.

Latest Patents

Jan's latest patents include groundbreaking research on the anti-inflammatory properties of a surface protein of Propionibacterium freudenreichii. This invention discloses a polypeptide that can be used in the treatment or prevention of inflammatory diseases. It encompasses a nucleic acid sequence encoding the polypeptide, a vector including the nucleic acid, and a host cell for therapeutic applications. Additionally, he has developed a pharmaceutical composition or food composition that includes these elements for treating inflammatory diseases. Another significant patent involves a recombinant vector designed for producing and secreting peptides or proteins of interest by propionibacteria. This invention has potential applications in the pharmaceutical field and for large-scale production of valuable peptides or proteins.

Career Highlights

Throughout his career, Jan has worked with esteemed institutions such as Université de Rennes 1 and the Institut National de la Santé et de la Recherche Médicale. His research has contributed to advancements in the understanding of immunomodulatory properties and their applications in medicine.

Collaborations

Jan has collaborated with notable colleagues, including Hélène Falentin and Marie-Thérèse Dimanche-Boitrel. These partnerships have further enriched his research and innovation in the field.

Conclusion

Gwenael Jan's contributions to immunomodulatory research through his patents highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of inflammatory diseases.